SlideShare una empresa de Scribd logo
1 de 54
Descargar para leer sin conexión
Enabling	
  and	
  Interven/on	
  
                 Karen	
  Perry	
  	
  
Co-­‐Founder,	
  Execu/ve	
  Director,	
  NOPE	
  
                  Task	
  Force	
  

       Dominique	
  Simon-­‐Levine	
  
       Director,	
  Allies	
  in	
  Recovery	
  	
  
Learning	
  Objec/ves	
  	
  
1.  Analyze	
  two	
  effec/ve	
  advocacy	
  programs	
  and	
  
    the	
  current	
  trends	
  of	
  Rx	
  drug	
  abuse.	
  
2.  	
  Describe	
  CRAFT	
  procedures	
  to	
  increase	
  the	
  
    chance	
  of	
  a	
  loved	
  one	
  entering	
  treatment.	
  
3.  Describe	
  the	
  methods	
  for	
  engaging	
  a	
  loved	
  
    one	
  to	
  seek	
  help.	
  
Disclosure	
  Statement	
  
•  Karen	
  Perry	
  has	
  no	
  financial	
  rela/onships	
  with	
  
   proprietary	
  en//es	
  that	
  produce	
  health	
  care	
  
   goods	
  and	
  services.	
  	
  
•  Dominique	
  Simon-­‐Levine	
  has	
  no	
  financial	
  
   rela/onships	
  with	
  proprietary	
  en//es	
  that	
  
   produce	
  health	
  care	
  goods	
  and	
  services.	
  	
  
Enabling	
  and	
  Interven/on	
  
         Karen	
  H.	
  Perry	
  
          Co-­‐Founder	
  
       Execu;ve	
  Director	
  
Richard	
  Perry	
  
   Age	
  21	
  
Richard	
  Perry	
  
   Age	
  21	
  
Na/onal	
  Overdose	
  Sta/s/cs	
  	
  
•  28,578	
  uninten/onal	
  fatal	
  drug	
  poisonings	
  (2009)	
  
•  In	
  2009,	
  approximately	
  1.2	
  Million	
  Emergency	
  Room	
  
   visits	
  for	
  non	
  medical	
  use	
  of	
  pharmaceu/cals.	
  	
  
•  Research	
  indicates	
  an	
  es/mated	
  6	
  people	
  will	
  be	
  
   directly	
  affected	
  by	
  each	
  sudden	
  loss,	
  which	
  equates	
  
   to	
  171,468	
  people	
  annually	
  
Current	
  Trends	
  	
  	
  
•  Every	
  day,	
  2,000	
  teens	
  in	
  the	
  
   United	
  States	
  try	
  prescrip/on	
  
   drugs	
  to	
  get	
  high	
  for	
  the	
  first	
  
   /me	
  
•  60%	
  of	
  teens	
  who	
  have	
  abused	
  
   prescrip/on	
  painkillers,	
  did	
  so	
  
   before	
  the	
  age	
  of	
  15	
  
•  45%	
  of	
  those	
  who	
  use	
  prior	
  to	
  
   the	
  age	
  of	
  15,	
  will	
  later	
  develop	
  
   an	
  addic/on	
  which	
  also	
  
   increases	
  the	
  chance	
  for	
  
   overdose.	
  	
  
Successful	
  Community	
  Partnerships	
  

•    Assess	
  the	
  Local	
  Community	
  
•    Forming	
  Partnerships	
  
•    Plan	
  and	
  Set	
  Goals	
  
•    Implement	
  	
  
Community	
  Partnerships	
  	
  
•    Law	
  Enforcement	
  
•    Medical	
  Examiner	
  
•    Community	
  Government	
  
•    Medical	
  Professionals	
  
•    Treatment	
  Providers	
  
•    Educa/onal	
  Ins/tu/ons	
  
•    Legislators	
  
•    Family	
  Members	
  
Assess	
  Local	
  Community	
  
    Partnership	
  with	
  Palm	
  Beach	
  County	
  Sheriff	
  Office	
  
•  Majority	
  died	
  from	
  a	
        •  Highest	
  spikes	
  occur	
  
   combina/on	
  of	
  drugs	
               between	
  ages	
  of	
  18-­‐30	
  an	
  
•  Prescrip/on	
  drugs	
  were	
            50-­‐60	
  
   found	
  in	
  majority	
  of	
        •  At	
  least	
  one	
  third	
  of	
  
   deaths	
                                  vic/ms	
  has	
  suffered	
  a	
  
•  Majority	
  of	
  deaths	
                previous	
  non-­‐fatal	
  
   someone	
  was	
  with	
  in	
            overdose	
  
   earshot	
  of	
  vic/m	
  
•  Majority	
  of	
  vic/ms	
  were	
  
   Caucasian	
  male	
  
NOPE	
  Task	
  Force™	
  a	
  501c-­‐3	
  non-­‐profit	
  


                Mission	
  
To	
  reduce	
  the	
  frequency	
  and	
  
impact	
  of	
  drug	
  overdose	
  
death	
  through:	
  	
  

• Community	
  Educa/on	
  	
  
• Family	
  Support	
  	
  
• 	
  Purposeful	
  Advocacy	
  
Plan	
  and	
  Set	
  Goals	
  	
  
•  Reduce	
  early	
  onset	
  of	
  
substance	
  use.	
  

•  Empower	
  youth	
  to	
  become	
  
peer	
  	
  advocates	
  Increase	
  
knowledge	
  of	
  parents	
  and	
  
community	
  members.	
  

•  Reduce	
  the	
  number	
  of	
  drug	
  
overdose	
  deaths.	
  	
  
Preven/on	
  &	
  Educa/on	
  


         Presenta/ons	
  
•  Middle	
  &	
  High	
  Schools	
  
•  Universi/es	
  
•  Parents	
  &	
  Communi/es	
  
•  Treatment	
  and	
  Correc/onal	
  
   ins/tu/ons	
  
•  Health	
  Care	
  Professionals	
  
Student	
  Presenta/ons	
  
          TOPICS	
  OF	
  DISCUSSION	
                RELATED	
  NOPE	
  TAG	
  LINES	
  
1.  Addic/on	
                                •  Be	
  the	
  Hero-­‐Tell	
  Someone	
  ®	
  

2.  Combining	
  Drugs	
  =	
  Overdose	
     •  One	
  Time	
  Can	
  Kill	
  ®	
  

3.  Make	
  the	
  Call!	
  Dial	
  911	
     •  Make	
  the	
  Call!	
  Dial	
  911	
  ®	
  
4.	
   	
  Passed	
  out=	
  Medical	
        •  Some/mes	
  You	
  Never	
  Sleep	
  It	
  
           Emergency	
  
                                                 Off	
  ®	
  
Parent	
  Presenta/on	
  
4	
  Components:	
  
•    Impact	
  on	
  family	
  
•    Underage	
  drinking	
  
•    Current	
  trends	
  
•    Paren/ng	
  strategies	
  
Follow	
  Up	
  	
  
•    ASK	
  ADAM	
  &	
  AMY	
  
•    Interac/ve	
  Website	
  
•    Publica/ons	
  	
  
•    Student	
  Cer/fica/on	
  
     and	
  Life	
  Choices	
  
     Scholarship	
  	
  
Efficacy	
  	
  


Empirical	
  support	
  
indicates	
  par/cipants	
  
show:	
  	
  
•  Change	
  in	
  knowledge	
  
•  Change	
  in	
  aktudes	
  
   towards	
  drug	
  	
  
Lynn	
  University	
  Research	
  
   Boca	
  Raton,	
  FL	
  	
  
Awareness	
  
•  Na/onal	
  Candle	
  Light	
  
   Vigil	
  
•  Interac/ve	
  Website	
  
•  Social	
  media	
  
•  Prescrip/on	
  Drug	
  Take	
  
   Back	
  
•  Advocates	
  for	
  legisla/ve	
  
   change	
  
Advocate	
  for	
  Legisla/on	
  
•  Be	
  informed	
  of	
  local	
  
   issues	
  and	
  poten/al	
  
   bills	
  	
  

•  Create	
  tool	
  kit	
  for	
  
   community	
  partners	
  

•  Inform	
  partners	
  of	
  
   upcoming	
  bills	
  	
  
Family	
  Support	
  
•    Treatment	
  Support	
  
•    ASK	
  ADAM	
  
•    Support	
  Groups	
  
•    Interac/ve	
  Website	
  
•    Publica/ons	
  	
  
NOPE	
  Task	
  Force’s	
  Accomplishments	
  

•  11	
  Chapters	
  across	
  Florida	
  	
     •  Florida	
  Prescrip/on	
  Drug	
  
•  Over	
  120,000	
  students	
                    Monitoring	
  Program	
  passed	
  
   receiving	
  our	
  evidence	
                   and	
  ac/ve	
  
   based	
  message	
  annually	
                •  Good	
  Samaritan	
  911	
  Law	
  
•  Over	
  50	
  loca/ons	
  hos/ng	
               passed	
  	
  
   Candle	
  Light	
  Vigils	
  Annually	
  
Partners	
  	
  
•    Office	
  of	
  Na/onal	
  Drug	
  Control	
  Policy	
         •    Mar/n	
  County	
  Sheriff’s	
  Office	
  
•    Florida	
  Office	
  of	
  the	
  Anorney	
  General	
  	
     •    Okeechobee	
  County	
  Sheriff’s	
  Office	
  
•    The	
  Florida	
  Sheriff’s	
  Associa/on	
                   •    Palm	
  Beach	
  County	
  Sheriff’s	
  Office	
  
•    The	
  Florida	
  Police	
  Chiefs	
  Associa/on	
           •    Palm	
  Beach	
  County	
  State	
  Anorney	
  	
  
•    Florida	
  Coali/on	
  Alliance	
                            •    Pinellas	
  County	
  Sheriff’s	
  Office	
  
•    Safe	
  and	
  Drug	
  Free	
  Schools	
                     •    St.	
  Lucie	
  County	
  Sheriff’s	
  Office	
  
•    Caron	
  Center	
                                            •    Sarasota	
  County	
  Sheriff’s	
  Office	
  
•    Hanley	
  Center	
                                           •    Seminole	
  County	
  Sheriff’s	
  and	
  	
  
•    Lynn	
  University	
                                              municipal	
  law	
  enforcement	
  agencies	
  
•    Flagler	
  County	
  Sheriff’s	
  Office	
                      •    Volusia	
  County	
  Sheriff’s	
  Office	
  
•    Hillsborough	
  County	
  Sheriff’s	
  Office	
  
•    Indian	
  River	
  County	
  Sheriff’s	
  Office	
  
NOPE	
  Task	
  Force	
  



    866-­‐612-­‐NOPE	
  
 www.nopetaskforce.org	
  

       Karen	
  Perry	
  
KPerry@NOPETaskForce.org	
  
 Enabling	
  and	
  Interven;on	
  

           When	
  Love	
  Isn’t	
  Enough…	
  
CRAFT	
  (Community	
  Reinforcement	
  and	
  Family	
  Training)	
  
             Dominique	
  Simon-­‐Levine,	
  PhD	
  

                       April	
  2	
  –	
  4,	
  2013	
  
                     Omni	
  Orlando	
  Resort	
  	
  
                      at	
  ChampionsGate	
  
Learning	
  Objec;ves	
  

1.	
  Understand	
  specific	
  CRAFT	
  procedures	
  (eg.	
  
reinforcement	
  strategies,	
  allowing	
  natural	
  
consequences)	
  to	
  increase	
  the	
  chance	
  that	
  the	
  
Loved	
  One	
  will	
  enter	
  treatment.	
  

2.	
  Understand	
  the	
  methods	
  for	
  engaging	
  a	
  Loved	
  
One	
  to	
  seek	
  help.	
  

3.	
  	
  Review	
  the	
  science	
  behind	
  CRAFT.	
  
Disclosure	
  Statement	
  

Dominique	
  Simon-­‐Levine	
  has	
  no	
  financial	
  
rela/onships	
  with	
  proprietary	
  en//es	
  that	
  
produce	
  health	
  care	
  goods	
  and	
  services.	
  
CRAFT	
  is	
  driven	
  by	
  the	
  principles	
  of	
  classical	
  
behavioralism.	
  



Dolphins	
  do	
  it,	
  dogs	
  do	
  it,	
  people	
  do	
  it…	
  
Control vs Influence:                                     !


Control	
                                Influence	
  
•  Demand,	
  dominate,	
                •  Request,	
  provide	
  resources,	
  you	
  
   manipulate	
                             are	
  a	
  mirror	
  “what	
  do	
  you	
  want	
  to	
  
                                            do?”	
  

•  “No”	
  leads	
  to	
  guil/ng,	
   •  “No”	
  leads	
  to	
  disappointment	
  and	
  
   anger,	
  shaming,	
                   provides	
  informa/on	
  
   resentment	
  

•  Power	
  over	
  	
                   •  Power	
  with,	
  it’s	
  a	
  partnership	
  

“Use	
  and	
  you’re	
  out	
  of	
     “Please	
  do	
  not	
  come	
  home	
  if	
  you’ve	
  
here.”	
  	
                             been	
  using.	
  	
  You’re	
  welcome	
  back	
  
                                         when	
  you	
  straighten	
  up.”	
  
The	
  Essen/al	
  Skill	
  Set:	
  CRAFT	
  
1.	
  	
  Safety,	
  de-­‐escala/on	
  

2.	
  Posi/ve	
  communica/on	
  

3.	
  What	
  to	
  do	
  when	
  your	
  LO	
  is	
  not	
  using,	
  right	
  now	
  

4.	
  What	
  to	
  do	
  when	
  your	
  LO	
  is	
  using,	
  right	
  now	
  

5.	
  How	
  to	
  handle	
  the	
  hard	
  emo/ons	
  

6.	
  How	
  to	
  get	
  your	
  LO	
  into	
  treatment	
  
CRAFT	
  happens	
  in	
  the	
  moment	
  
…	
  the	
  world	
  divides	
  in	
  two.	
  	
  	
  


•      	
   How	
  you	
  respond	
  when	
  you	
  see	
  use	
  

•      	
   How	
  you	
  respond	
  when	
  you	
  don’t	
  see	
  use	
  
When	
  you	
  see	
  use,	
  disable	
  the	
  enabling	
  …	
  

1)	
  Remove	
  the	
  rewards.	
  

2)	
  Remove	
  yourself	
  in	
  a	
  quiet	
  neutral	
  way.	
  	
  

3)	
  Allow	
  natural	
  consequences,	
  if	
  safe	
  to	
  
do	
  so.	
  	
  	
  
.	
  	
  
When	
  you	
  don’t	
  see	
  use….*!+REWARD+!*	
  
4	
  Characteris/cs	
  
  pleasurable	
  to	
  your	
  LO	
  
  free	
  or	
  affordable	
  	
  
  can	
  be	
  given	
  immediately	
  	
  
  something	
  you	
  are	
  willing	
  to	
  give	
  

4	
  Types	
  
Stuff:	
  like	
  a	
  video	
  game	
  or	
  /x	
  to	
  a	
  ball	
  game	
  or	
  a	
  favorite	
  food.	
  
Verbal	
  comments:	
  “It	
  really	
  saves	
  me	
  /me	
  when	
  you	
  take	
  out	
  the	
  trash.	
  
Non	
  verbal	
  behaviors:	
  eye	
  contact	
  or	
  a	
  pat	
  on	
  the	
  back.	
  	
  
Ac;vi;es:	
  a	
  back	
  rub,	
  a	
  walk	
  to	
  the	
  corner	
  for	
  ice	
  cream.	
  
How	
  do	
  I	
  get	
  my	
  Loved	
  One	
  into	
  treatment?	
  
•  You	
  create	
  that	
  bridge	
  between	
  the	
  two	
  of	
  you.	
  	
  

•  You	
  empathize	
  and	
  show	
  respect.	
  	
  	
  

•  You	
  stop	
  the	
  nega/ve	
  talk,	
  add	
  in	
  posi/ve	
  talk,	
  and	
  listen	
  	
  
to	
  what	
  your	
  LO	
  is	
  saying.	
  	
  	
  

•  You	
  make	
  requests.	
  	
  You	
  don’t	
  dominate.	
  	
  	
  

•  You	
  take	
  care	
  of	
  yourself,	
  which	
  helps	
  you	
  stay	
  calm	
  
	
  and	
  pa/ent.	
  	
  	
  

•  You	
  understand	
  that	
  gekng	
  sober	
  and	
  clean	
  is	
  a	
  process.	
  	
  	
  
 You	
  have	
  treatment	
  in	
  your	
  back	
  pocket.	
  	
  

 Treatment	
  defined	
  broadly:	
  public,	
  private,	
  self-­‐help,	
  	
  
faith-­‐based..	
  

Windows	
  of	
  Opportunity	
  
1)	
  A	
  wish	
  or	
  a	
  dip…Change	
  Talk,	
  there’s	
  mo/va/on	
  in	
  this.	
  
2)	
  The	
  planned	
  conversa/on.	
  	
  A	
  serious	
  moment	
  around	
  the	
  table.	
  
3)	
  When	
  LO	
  talks	
  of	
  gekng	
  help.	
  

 Script	
  it	
  out.	
  Avoid	
  jargon	
  and	
  words	
  like	
  alcoholic,	
  drug	
  addict,	
  	
  
treatment…	
  	
  

 Rehearse	
  it.	
  

 Prepare	
  for	
  refusal.	
  
Sandy’s	
  Tea	
  Party	
  
I	
  hate	
  that	
  I	
  don’t	
  want	
  to	
  have	
  sex	
  with	
  you.	
  	
  Only	
  
recently	
  has	
  there	
  been	
  any	
  closeness	
  at	
  all.	
  	
  I	
  don’t	
  
want	
  any	
  more	
  weekends	
  like	
  the	
  last	
  one.	
  	
  We	
  aren’t	
  
enjoying	
  each	
  other.	
  	
  I	
  think	
  we’re	
  both	
  isolated	
  and	
  
lonely.	
  	
  I	
  want	
  us	
  connected	
  again.	
  	
  I	
  want	
  you.	
  	
  That	
  
isn’t	
  possible	
  with	
  your	
  drinking.	
  	
  
Come	
  see	
  me.	
  
I	
  have	
  a	
  list	
  of	
  places	
  that	
  help	
  professionals	
  who	
  have	
  
problems	
  with	
  drinking.	
  	
  Will	
  you	
  take	
  a	
  look	
  at	
  it	
  with	
  
me?	
  
Controlled	
  Trial	
  
           130	
  family	
  members	
  assigned	
  to	
  1	
  of	
  3	
  interven/ons	
  

"   Al-­‐Anon	
  Facilita/on	
  therapy	
  
"   Johnson	
  Ins/tute	
  Interven/on	
  
"   CRAFT	
  	
  	
  
"   Loved	
  Ones	
  are	
  all	
  alcoholic	
  
Family	
  Member	
  Depression	
  (Becks)	
  
Sisson &     Miller,
                                CRAFT	
  STUDIES	
  
                          Kirby, et al.,   Meyers,           Meyers,           Waldron,        Dutcher, et   Manual, et
Azrin        Meyers, et   1999             Miller, et al.,   Miller, et al.,   et. al., 2007   al., 1999     al., 2011
1986         al., 1999                     1999              2002              adolescent                    Group vs
                                                                                                             Self-
                                                                                                             Directed

14 CSOs      130 CSOs     32 CSOs          62 CSOs           90 CSOs           42 CSOs         99 CSOs       40 CSOs
                          75% Anglo        80%               49%               48%             59%           60% Anglo
                          23% AA           Hispanic          Hispanic          Hispanic        Hispanic

Alcohol      Alcohol      55%              37% Coca          MJ         MJ                     Alcohol       Drugs/
                          Cocaine          35% MJ            Cocaine    Alcohol                90%           Alcohol
                          22%              16% Stim          Stimulants                        Cocaine
                          opiates          8% opiate                                           7%
Randomized   Randomized   Randomized       Non-              Randomized        Non-            Non-          Craft in
(CRAFT vs    (CRAFT/JI    (CRAFT vs        Randomized                          Randomized      Randomized    Group vs
12 Step)     /12-step     12-step)                                                                           Self-
                                                                                                             Directed

86% vs       64%          74% vs           74%               65.5% vs          71%             55%-65%       70%
0%           vs23%        17%              CSOs              29%               CSOs            CSOs          vs 40%
CSOs         vs13%        CSOs             Better            CSOs              Better          Better        Better
Better       CSOs         Better                             Better
             Better
Other	
  Outcomes	
  from	
  Clinical	
  Trials	
  

"  CRAFT-­‐engaged	
  Loved	
  Ones	
  most	
  owen	
  
   anend	
  6	
  sessions	
  of	
  outpa/ent	
  treatment	
  as	
  
   compared	
  to	
  NM	
  state	
  modal	
  of	
  1.	
  

"  Loved	
  Ones	
  reduce	
  their	
  use	
  by	
  50%	
  while	
  
   family	
  member	
  is	
  in	
  CRAFT	
  
CRAFT	
  Resources	
  

Dr.	
  Robert	
  Meyers,	
  William	
  Miller,	
  Jane	
  Ellen	
  Smith,	
  
University	
  of	
  New	
  Mexico,	
  Center	
  on	
  Alcoholism,	
  Substance	
  
Abuse,	
  and	
  Addic/ons	
  	
  

HBO	
  film	
  on	
  CRAFT	
  
hnp://www.hbo.com/addic/on/thefilm/supplemental/
628_addict_into_treatment.html	
  

Dominique	
  Simon-­‐Levine	
  
dominiquesimon@comcast.net	
  
Simonlevine.com	
  

Más contenido relacionado

La actualidad más candente

La actualidad más candente (8)

Michelle Lipinski
Michelle LipinskiMichelle Lipinski
Michelle Lipinski
 
Drug trafficking: Causes & Consequences
Drug trafficking: Causes & ConsequencesDrug trafficking: Causes & Consequences
Drug trafficking: Causes & Consequences
 
Prevention
PreventionPrevention
Prevention
 
Hostile agressive parenting
Hostile agressive parentingHostile agressive parenting
Hostile agressive parenting
 
Puff or Pass part 3 - Monica Morten
Puff or Pass part 3 - Monica MortenPuff or Pass part 3 - Monica Morten
Puff or Pass part 3 - Monica Morten
 
MTR Rosa Parks Lecture 2.10.11
MTR Rosa Parks Lecture 2.10.11MTR Rosa Parks Lecture 2.10.11
MTR Rosa Parks Lecture 2.10.11
 
Sample report
Sample reportSample report
Sample report
 
Hiv & intimate partner violence
Hiv & intimate partner violenceHiv & intimate partner violence
Hiv & intimate partner violence
 

Destacado

Treatment options for_juveniles_final
Treatment options for_juveniles_finalTreatment options for_juveniles_final
Treatment options for_juveniles_finalOPUNITE
 
Trends in rx_drug_abuse_final
Trends in rx_drug_abuse_finalTrends in rx_drug_abuse_final
Trends in rx_drug_abuse_finalOPUNITE
 
Treatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_finalTreatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_finalOPUNITE
 
Building public safety_public_health_partnerships_final
Building public safety_public_health_partnerships_finalBuilding public safety_public_health_partnerships_final
Building public safety_public_health_partnerships_finalOPUNITE
 
Technologies in preventing_diversion-ne_wweb
Technologies in preventing_diversion-ne_wwebTechnologies in preventing_diversion-ne_wweb
Technologies in preventing_diversion-ne_wwebOPUNITE
 
Successful strategies for_community_change_part1_final
Successful strategies for_community_change_part1_finalSuccessful strategies for_community_change_part1_final
Successful strategies for_community_change_part1_finalOPUNITE
 
Realities of addiction_volkow-final
Realities of addiction_volkow-finalRealities of addiction_volkow-final
Realities of addiction_volkow-finalOPUNITE
 
Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse pptDFC2011
 

Destacado (9)

Treatment options for_juveniles_final
Treatment options for_juveniles_finalTreatment options for_juveniles_final
Treatment options for_juveniles_final
 
Trends in rx_drug_abuse_final
Trends in rx_drug_abuse_finalTrends in rx_drug_abuse_final
Trends in rx_drug_abuse_final
 
Treatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_finalTreatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_final
 
Building public safety_public_health_partnerships_final
Building public safety_public_health_partnerships_finalBuilding public safety_public_health_partnerships_final
Building public safety_public_health_partnerships_final
 
Technologies in preventing_diversion-ne_wweb
Technologies in preventing_diversion-ne_wwebTechnologies in preventing_diversion-ne_wweb
Technologies in preventing_diversion-ne_wweb
 
Successful strategies for_community_change_part1_final
Successful strategies for_community_change_part1_finalSuccessful strategies for_community_change_part1_final
Successful strategies for_community_change_part1_final
 
Realities of addiction_volkow-final
Realities of addiction_volkow-finalRealities of addiction_volkow-final
Realities of addiction_volkow-final
 
Amalgam cavity design
Amalgam cavity designAmalgam cavity design
Amalgam cavity design
 
Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse ppt
 

Similar a Enabling and intervention_final

Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonOPUNITE
 
Ea 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeEa 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeOPUNITE
 
Len 5 joint presentation
Len 5 joint presentationLen 5 joint presentation
Len 5 joint presentationOPUNITE
 
Karen Perry
Karen PerryKaren Perry
Karen PerryOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Ea 7 melton lopez_peters
Ea 7 melton lopez_petersEa 7 melton lopez_peters
Ea 7 melton lopez_petersOPUNITE
 
How a Small Coalitions Leveraged Resources To Protect Children
How a Small Coalitions Leveraged Resources To Protect ChildrenHow a Small Coalitions Leveraged Resources To Protect Children
How a Small Coalitions Leveraged Resources To Protect ChildrenHealth Easy Peasy
 
Prevention of the Sexual Abuse of Children (English Version)
Prevention of the Sexual Abuse of Children (English Version)Prevention of the Sexual Abuse of Children (English Version)
Prevention of the Sexual Abuse of Children (English Version)neilmcq
 
Rx15 ea wed_430_1_teater_2kennard_3washington
Rx15 ea wed_430_1_teater_2kennard_3washingtonRx15 ea wed_430_1_teater_2kennard_3washington
Rx15 ea wed_430_1_teater_2kennard_3washingtonOPUNITE
 
Rx15 vision tues_800_uk
Rx15 vision tues_800_ukRx15 vision tues_800_uk
Rx15 vision tues_800_ukOPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyOPUNITE
 
Tink Palmer,MCF, Presentation for day workshop.
Tink Palmer,MCF,  Presentation for day workshop. Tink Palmer,MCF,  Presentation for day workshop.
Tink Palmer,MCF, Presentation for day workshop. mckenln
 
Week #4 sbirt attc webinar series
Week #4  sbirt attc webinar seriesWeek #4  sbirt attc webinar series
Week #4 sbirt attc webinar seriesbrittneyleanngraves
 
Child Maltreatment and Child Welfare
Child Maltreatment and Child WelfareChild Maltreatment and Child Welfare
Child Maltreatment and Child WelfareMitchell Hortert
 
Bullyingamongyouthkrh 101207111220-phpapp02
Bullyingamongyouthkrh 101207111220-phpapp02Bullyingamongyouthkrh 101207111220-phpapp02
Bullyingamongyouthkrh 101207111220-phpapp02RWDouglasLCSW
 
Tlr nas stockton behringer
Tlr nas stockton behringerTlr nas stockton behringer
Tlr nas stockton behringerOPUNITE
 
Harm reduction
Harm reductionHarm reduction
Harm reductiongriehl
 
Bullying Among Youth krh Powerpoint Presentation
Bullying Among Youth krh Powerpoint PresentationBullying Among Youth krh Powerpoint Presentation
Bullying Among Youth krh Powerpoint PresentationJohn M. Rinaldi
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 

Similar a Enabling and intervention_final (20)

Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
Ea 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeEa 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heeke
 
Len 5 joint presentation
Len 5 joint presentationLen 5 joint presentation
Len 5 joint presentation
 
Karen Perry
Karen PerryKaren Perry
Karen Perry
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Ea 7 melton lopez_peters
Ea 7 melton lopez_petersEa 7 melton lopez_peters
Ea 7 melton lopez_peters
 
How a Small Coalitions Leveraged Resources To Protect Children
How a Small Coalitions Leveraged Resources To Protect ChildrenHow a Small Coalitions Leveraged Resources To Protect Children
How a Small Coalitions Leveraged Resources To Protect Children
 
Prevention of the Sexual Abuse of Children (English Version)
Prevention of the Sexual Abuse of Children (English Version)Prevention of the Sexual Abuse of Children (English Version)
Prevention of the Sexual Abuse of Children (English Version)
 
Parents
ParentsParents
Parents
 
Rx15 ea wed_430_1_teater_2kennard_3washington
Rx15 ea wed_430_1_teater_2kennard_3washingtonRx15 ea wed_430_1_teater_2kennard_3washington
Rx15 ea wed_430_1_teater_2kennard_3washington
 
Rx15 vision tues_800_uk
Rx15 vision tues_800_ukRx15 vision tues_800_uk
Rx15 vision tues_800_uk
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Tink Palmer,MCF, Presentation for day workshop.
Tink Palmer,MCF,  Presentation for day workshop. Tink Palmer,MCF,  Presentation for day workshop.
Tink Palmer,MCF, Presentation for day workshop.
 
Week #4 sbirt attc webinar series
Week #4  sbirt attc webinar seriesWeek #4  sbirt attc webinar series
Week #4 sbirt attc webinar series
 
Child Maltreatment and Child Welfare
Child Maltreatment and Child WelfareChild Maltreatment and Child Welfare
Child Maltreatment and Child Welfare
 
Bullyingamongyouthkrh 101207111220-phpapp02
Bullyingamongyouthkrh 101207111220-phpapp02Bullyingamongyouthkrh 101207111220-phpapp02
Bullyingamongyouthkrh 101207111220-phpapp02
 
Tlr nas stockton behringer
Tlr nas stockton behringerTlr nas stockton behringer
Tlr nas stockton behringer
 
Harm reduction
Harm reductionHarm reduction
Harm reduction
 
Bullying Among Youth krh Powerpoint Presentation
Bullying Among Youth krh Powerpoint PresentationBullying Among Youth krh Powerpoint Presentation
Bullying Among Youth krh Powerpoint Presentation
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 

Más de OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 

Más de OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 

Enabling and intervention_final

  • 1. Enabling  and  Interven/on   Karen  Perry     Co-­‐Founder,  Execu/ve  Director,  NOPE   Task  Force   Dominique  Simon-­‐Levine   Director,  Allies  in  Recovery    
  • 2. Learning  Objec/ves     1.  Analyze  two  effec/ve  advocacy  programs  and   the  current  trends  of  Rx  drug  abuse.   2.   Describe  CRAFT  procedures  to  increase  the   chance  of  a  loved  one  entering  treatment.   3.  Describe  the  methods  for  engaging  a  loved   one  to  seek  help.  
  • 3. Disclosure  Statement   •  Karen  Perry  has  no  financial  rela/onships  with   proprietary  en//es  that  produce  health  care   goods  and  services.     •  Dominique  Simon-­‐Levine  has  no  financial   rela/onships  with  proprietary  en//es  that   produce  health  care  goods  and  services.    
  • 4. Enabling  and  Interven/on   Karen  H.  Perry   Co-­‐Founder   Execu;ve  Director  
  • 5. Richard  Perry   Age  21  
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Richard  Perry   Age  21  
  • 17.
  • 18. Na/onal  Overdose  Sta/s/cs     •  28,578  uninten/onal  fatal  drug  poisonings  (2009)   •  In  2009,  approximately  1.2  Million  Emergency  Room   visits  for  non  medical  use  of  pharmaceu/cals.     •  Research  indicates  an  es/mated  6  people  will  be   directly  affected  by  each  sudden  loss,  which  equates   to  171,468  people  annually  
  • 19. Current  Trends       •  Every  day,  2,000  teens  in  the   United  States  try  prescrip/on   drugs  to  get  high  for  the  first   /me   •  60%  of  teens  who  have  abused   prescrip/on  painkillers,  did  so   before  the  age  of  15   •  45%  of  those  who  use  prior  to   the  age  of  15,  will  later  develop   an  addic/on  which  also   increases  the  chance  for   overdose.    
  • 20. Successful  Community  Partnerships   •  Assess  the  Local  Community   •  Forming  Partnerships   •  Plan  and  Set  Goals   •  Implement    
  • 21. Community  Partnerships     •  Law  Enforcement   •  Medical  Examiner   •  Community  Government   •  Medical  Professionals   •  Treatment  Providers   •  Educa/onal  Ins/tu/ons   •  Legislators   •  Family  Members  
  • 22. Assess  Local  Community   Partnership  with  Palm  Beach  County  Sheriff  Office   •  Majority  died  from  a   •  Highest  spikes  occur   combina/on  of  drugs   between  ages  of  18-­‐30  an   •  Prescrip/on  drugs  were   50-­‐60   found  in  majority  of   •  At  least  one  third  of   deaths   vic/ms  has  suffered  a   •  Majority  of  deaths   previous  non-­‐fatal   someone  was  with  in   overdose   earshot  of  vic/m   •  Majority  of  vic/ms  were   Caucasian  male  
  • 23. NOPE  Task  Force™  a  501c-­‐3  non-­‐profit   Mission   To  reduce  the  frequency  and   impact  of  drug  overdose   death  through:     • Community  Educa/on     • Family  Support     •   Purposeful  Advocacy  
  • 24. Plan  and  Set  Goals     •  Reduce  early  onset  of   substance  use.   •  Empower  youth  to  become   peer    advocates  Increase   knowledge  of  parents  and   community  members.   •  Reduce  the  number  of  drug   overdose  deaths.    
  • 25. Preven/on  &  Educa/on   Presenta/ons   •  Middle  &  High  Schools   •  Universi/es   •  Parents  &  Communi/es   •  Treatment  and  Correc/onal   ins/tu/ons   •  Health  Care  Professionals  
  • 26. Student  Presenta/ons   TOPICS  OF  DISCUSSION   RELATED  NOPE  TAG  LINES   1.  Addic/on   •  Be  the  Hero-­‐Tell  Someone  ®   2.  Combining  Drugs  =  Overdose   •  One  Time  Can  Kill  ®   3.  Make  the  Call!  Dial  911   •  Make  the  Call!  Dial  911  ®   4.    Passed  out=  Medical   •  Some/mes  You  Never  Sleep  It   Emergency   Off  ®  
  • 27. Parent  Presenta/on   4  Components:   •  Impact  on  family   •  Underage  drinking   •  Current  trends   •  Paren/ng  strategies  
  • 28. Follow  Up     •  ASK  ADAM  &  AMY   •  Interac/ve  Website   •  Publica/ons     •  Student  Cer/fica/on   and  Life  Choices   Scholarship    
  • 29. Efficacy     Empirical  support   indicates  par/cipants   show:     •  Change  in  knowledge   •  Change  in  aktudes   towards  drug     Lynn  University  Research   Boca  Raton,  FL    
  • 30. Awareness   •  Na/onal  Candle  Light   Vigil   •  Interac/ve  Website   •  Social  media   •  Prescrip/on  Drug  Take   Back   •  Advocates  for  legisla/ve   change  
  • 31. Advocate  for  Legisla/on   •  Be  informed  of  local   issues  and  poten/al   bills     •  Create  tool  kit  for   community  partners   •  Inform  partners  of   upcoming  bills    
  • 32. Family  Support   •  Treatment  Support   •  ASK  ADAM   •  Support  Groups   •  Interac/ve  Website   •  Publica/ons    
  • 33. NOPE  Task  Force’s  Accomplishments   •  11  Chapters  across  Florida     •  Florida  Prescrip/on  Drug   •  Over  120,000  students   Monitoring  Program  passed   receiving  our  evidence   and  ac/ve   based  message  annually   •  Good  Samaritan  911  Law   •  Over  50  loca/ons  hos/ng   passed     Candle  Light  Vigils  Annually  
  • 34. Partners     •  Office  of  Na/onal  Drug  Control  Policy   •  Mar/n  County  Sheriff’s  Office   •  Florida  Office  of  the  Anorney  General     •  Okeechobee  County  Sheriff’s  Office   •  The  Florida  Sheriff’s  Associa/on   •  Palm  Beach  County  Sheriff’s  Office   •  The  Florida  Police  Chiefs  Associa/on   •  Palm  Beach  County  State  Anorney     •  Florida  Coali/on  Alliance   •  Pinellas  County  Sheriff’s  Office   •  Safe  and  Drug  Free  Schools   •  St.  Lucie  County  Sheriff’s  Office   •  Caron  Center   •  Sarasota  County  Sheriff’s  Office   •  Hanley  Center   •  Seminole  County  Sheriff’s  and     •  Lynn  University   municipal  law  enforcement  agencies   •  Flagler  County  Sheriff’s  Office   •  Volusia  County  Sheriff’s  Office   •  Hillsborough  County  Sheriff’s  Office   •  Indian  River  County  Sheriff’s  Office  
  • 35. NOPE  Task  Force   866-­‐612-­‐NOPE   www.nopetaskforce.org   Karen  Perry   KPerry@NOPETaskForce.org  
  • 36.  Enabling  and  Interven;on   When  Love  Isn’t  Enough…   CRAFT  (Community  Reinforcement  and  Family  Training)   Dominique  Simon-­‐Levine,  PhD   April  2  –  4,  2013   Omni  Orlando  Resort     at  ChampionsGate  
  • 37. Learning  Objec;ves   1.  Understand  specific  CRAFT  procedures  (eg.   reinforcement  strategies,  allowing  natural   consequences)  to  increase  the  chance  that  the   Loved  One  will  enter  treatment.   2.  Understand  the  methods  for  engaging  a  Loved   One  to  seek  help.   3.    Review  the  science  behind  CRAFT.  
  • 38. Disclosure  Statement   Dominique  Simon-­‐Levine  has  no  financial   rela/onships  with  proprietary  en//es  that   produce  health  care  goods  and  services.  
  • 39. CRAFT  is  driven  by  the  principles  of  classical   behavioralism.   Dolphins  do  it,  dogs  do  it,  people  do  it…  
  • 40.
  • 41. Control vs Influence: ! Control   Influence   •  Demand,  dominate,   •  Request,  provide  resources,  you   manipulate   are  a  mirror  “what  do  you  want  to   do?”   •  “No”  leads  to  guil/ng,   •  “No”  leads  to  disappointment  and   anger,  shaming,   provides  informa/on   resentment   •  Power  over     •  Power  with,  it’s  a  partnership   “Use  and  you’re  out  of   “Please  do  not  come  home  if  you’ve   here.”     been  using.    You’re  welcome  back   when  you  straighten  up.”  
  • 42. The  Essen/al  Skill  Set:  CRAFT   1.    Safety,  de-­‐escala/on   2.  Posi/ve  communica/on   3.  What  to  do  when  your  LO  is  not  using,  right  now   4.  What  to  do  when  your  LO  is  using,  right  now   5.  How  to  handle  the  hard  emo/ons   6.  How  to  get  your  LO  into  treatment  
  • 43. CRAFT  happens  in  the  moment   …  the  world  divides  in  two.       •    How  you  respond  when  you  see  use   •    How  you  respond  when  you  don’t  see  use  
  • 44. When  you  see  use,  disable  the  enabling  …   1)  Remove  the  rewards.   2)  Remove  yourself  in  a  quiet  neutral  way.     3)  Allow  natural  consequences,  if  safe  to   do  so.       .    
  • 45. When  you  don’t  see  use….*!+REWARD+!*   4  Characteris/cs     pleasurable  to  your  LO     free  or  affordable       can  be  given  immediately       something  you  are  willing  to  give   4  Types   Stuff:  like  a  video  game  or  /x  to  a  ball  game  or  a  favorite  food.   Verbal  comments:  “It  really  saves  me  /me  when  you  take  out  the  trash.   Non  verbal  behaviors:  eye  contact  or  a  pat  on  the  back.     Ac;vi;es:  a  back  rub,  a  walk  to  the  corner  for  ice  cream.  
  • 46. How  do  I  get  my  Loved  One  into  treatment?   •  You  create  that  bridge  between  the  two  of  you.     •  You  empathize  and  show  respect.       •  You  stop  the  nega/ve  talk,  add  in  posi/ve  talk,  and  listen     to  what  your  LO  is  saying.       •  You  make  requests.    You  don’t  dominate.       •  You  take  care  of  yourself,  which  helps  you  stay  calm    and  pa/ent.       •  You  understand  that  gekng  sober  and  clean  is  a  process.      
  • 47.  You  have  treatment  in  your  back  pocket.      Treatment  defined  broadly:  public,  private,  self-­‐help,     faith-­‐based..   Windows  of  Opportunity   1)  A  wish  or  a  dip…Change  Talk,  there’s  mo/va/on  in  this.   2)  The  planned  conversa/on.    A  serious  moment  around  the  table.   3)  When  LO  talks  of  gekng  help.    Script  it  out.  Avoid  jargon  and  words  like  alcoholic,  drug  addict,     treatment…      Rehearse  it.    Prepare  for  refusal.  
  • 48. Sandy’s  Tea  Party   I  hate  that  I  don’t  want  to  have  sex  with  you.    Only   recently  has  there  been  any  closeness  at  all.    I  don’t   want  any  more  weekends  like  the  last  one.    We  aren’t   enjoying  each  other.    I  think  we’re  both  isolated  and   lonely.    I  want  us  connected  again.    I  want  you.    That   isn’t  possible  with  your  drinking.     Come  see  me.   I  have  a  list  of  places  that  help  professionals  who  have   problems  with  drinking.    Will  you  take  a  look  at  it  with   me?  
  • 49. Controlled  Trial   130  family  members  assigned  to  1  of  3  interven/ons   "   Al-­‐Anon  Facilita/on  therapy   "   Johnson  Ins/tute  Interven/on   "   CRAFT       "   Loved  Ones  are  all  alcoholic  
  • 50.
  • 52. Sisson & Miller, CRAFT  STUDIES   Kirby, et al., Meyers, Meyers, Waldron, Dutcher, et Manual, et Azrin Meyers, et 1999 Miller, et al., Miller, et al., et. al., 2007 al., 1999 al., 2011 1986 al., 1999 1999 2002 adolescent Group vs Self- Directed 14 CSOs 130 CSOs 32 CSOs 62 CSOs 90 CSOs 42 CSOs 99 CSOs 40 CSOs 75% Anglo 80% 49% 48% 59% 60% Anglo 23% AA Hispanic Hispanic Hispanic Hispanic Alcohol Alcohol 55% 37% Coca MJ MJ Alcohol Drugs/ Cocaine 35% MJ Cocaine Alcohol 90% Alcohol 22% 16% Stim Stimulants Cocaine opiates 8% opiate 7% Randomized Randomized Randomized Non- Randomized Non- Non- Craft in (CRAFT vs (CRAFT/JI (CRAFT vs Randomized Randomized Randomized Group vs 12 Step) /12-step 12-step) Self- Directed 86% vs 64% 74% vs 74% 65.5% vs 71% 55%-65% 70% 0% vs23% 17% CSOs 29% CSOs CSOs vs 40% CSOs vs13% CSOs Better CSOs Better Better Better Better CSOs Better Better Better
  • 53. Other  Outcomes  from  Clinical  Trials   "  CRAFT-­‐engaged  Loved  Ones  most  owen   anend  6  sessions  of  outpa/ent  treatment  as   compared  to  NM  state  modal  of  1.   "  Loved  Ones  reduce  their  use  by  50%  while   family  member  is  in  CRAFT  
  • 54. CRAFT  Resources   Dr.  Robert  Meyers,  William  Miller,  Jane  Ellen  Smith,   University  of  New  Mexico,  Center  on  Alcoholism,  Substance   Abuse,  and  Addic/ons     HBO  film  on  CRAFT   hnp://www.hbo.com/addic/on/thefilm/supplemental/ 628_addict_into_treatment.html   Dominique  Simon-­‐Levine   dominiquesimon@comcast.net   Simonlevine.com